Literature DB >> 16493408

Serological screening of Tick-borne encephalitis (TBE) among Malaysian encephalitis patients.

Ravindran Thayan1, Nor Shahidah Khairullah, Ho Tze Ming.   

Abstract

Tick-borne encephalitis (TBE) is a viral infection of the central nervous system and is caused by tick bites, usually after travel to rural or forested areas. The disease is prevalent in Scandinavia, Western Europe, Central Europe and the former Soviet Union and East Asia including Japan. In Malaysia, so far there are no reported cases of TBE. In the present time, many illnesses have been attributed to traveling to other parts of the world. Thus it is important to carry out TBE prevalence study to determine whether the virus is present among Malaysian population. Samples (sera and CSF) from patients admitted to major MOH hospitals in Peninsular Malaysia and Sabah with a clinical diagnosis of encephalitis but is IgM negative for JE, were tested for TBEV IgM ELISA and TBEV IgG ELISA (DRG, Germany). Out of the 600 samples screened for TBEV IgG, all were non-reactive. In addition, out of the 100 samples screened for TBEV IgM, all the samples were also non-reactive. Our results indicate that currently TBE is not present in the Malaysian population. Among the reasons for this could be lack of the infection agent, absence of the suitable vector or subjects selected for the study did not fit the criteria of possible exposure to TBE infections. Hence we recommend that for any future study, the selection of subjects should include those who returned from tick-infested forested areas.

Entities:  

Year:  2004        PMID: 16493408

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  1 in total

1.  Seroprevalence report on tick-borne encephalitis virus and Crimean-Congo hemorrhagic fever virus among Malaysian's farm workers.

Authors:  Munirah Mohd Shukri; Kai Ling Kho; Masoumeh Ghane Kisomi; Rafidah Lani; Suria Marlina; Siti Fatimah Muhd Radzi; Sun Tee Tay; Li Ping Wong; Awang Bulgiba Awang Mahmud; Quaza Nizamuddin Hassan Nizam; Sazaly Abu Bakar; Keivan Zandi
Journal:  BMC Public Health       Date:  2015-07-24       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.